198 related articles for article (PubMed ID: 30235249)
21. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
[TBL] [Abstract][Full Text] [Related]
22. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H
Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161
[TBL] [Abstract][Full Text] [Related]
23. A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.
Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Carlus FH; Al-Mazroea AH; Morsy MM; Abo-Haded HM; Abdallah AM; Al-Harbi KM
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7732-7744. PubMed ID: 32744700
[TBL] [Abstract][Full Text] [Related]
24. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
Ingles J; Goldstein J; Thaxton C; Caleshu C; Corty EW; Crowley SB; Dougherty K; Harrison SM; McGlaughon J; Milko LV; Morales A; Seifert BA; Strande N; Thomson K; Peter van Tintelen J; Wallace K; Walsh R; Wells Q; Whiffin N; Witkowski L; Semsarian C; Ware JS; Hershberger RE; Funke B
Circ Genom Precis Med; 2019 Feb; 12(2):e002460. PubMed ID: 30681346
[TBL] [Abstract][Full Text] [Related]
26. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
Brito D; Richard P; Komajda M; Madeira H
Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: A case report.
Chen X; Jiang J; Zhu W; Wu Y; Su M
Medicine (Baltimore); 2019 Mar; 98(12):e14676. PubMed ID: 30896616
[TBL] [Abstract][Full Text] [Related]
28. Gene mutations in apical hypertrophic cardiomyopathy.
Arad M; Penas-Lado M; Monserrat L; Maron BJ; Sherrid M; Ho CY; Barr S; Karim A; Olson TM; Kamisago M; Seidman JG; Seidman CE
Circulation; 2005 Nov; 112(18):2805-11. PubMed ID: 16267253
[TBL] [Abstract][Full Text] [Related]
29. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
Lopes LR; Syrris P; Guttmann OP; O'Mahony C; Tang HC; Dalageorgou C; Jenkins S; Hubank M; Monserrat L; McKenna WJ; Plagnol V; Elliott PM
Heart; 2015 Feb; 101(4):294-301. PubMed ID: 25351510
[TBL] [Abstract][Full Text] [Related]
30. Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects.
Wessels MW; Herkert JC; Frohn-Mulder IM; Dalinghaus M; van den Wijngaard A; de Krijger RR; Michels M; de Coo IF; Hoedemaekers YM; Dooijes D
Eur J Hum Genet; 2015 Jul; 23(7):922-8. PubMed ID: 25335496
[TBL] [Abstract][Full Text] [Related]
31. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant.
Lorca R; Gómez J; Martín M; Cabanillas R; Calvo J; León V; Pascual I; Morís C; Coto E; R Reguero JJ
Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):138-144. PubMed ID: 29631964
[TBL] [Abstract][Full Text] [Related]
32. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
[TBL] [Abstract][Full Text] [Related]
33. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
Wu F; Li X; Bai R; Li Y; Gao J; Lan F
Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
[TBL] [Abstract][Full Text] [Related]
34. Progress in the molecular genetics of hypertrophic cardiomyopathy: a mini-review.
Tian T; Liu Y; Zhou X; Song L
Gerontology; 2013; 59(3):199-205. PubMed ID: 23363806
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy.
Ader F; Jedraszak G; Janin A; Billon C; Buisson NR; Bloch A; Bensalah M; De Sandre-Giovannoli A; Goudal A; Marsili L; Cazeneuve C; Charron P; Millat G; Richard P;
Clin Genet; 2024 Jun; 105(6):676-682. PubMed ID: 38356193
[TBL] [Abstract][Full Text] [Related]
36. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Lopes LR; Garcia-Hernández S; Lorenzini M; Futema M; Chumakova O; Zateyshchikov D; Isidoro-Garcia M; Villacorta E; Escobar-Lopez L; Garcia-Pavia P; Bilbao R; Dobarro D; Sandin-Fuentes M; Catalli C; Gener Querol B; Mezcua A; Garcia Pinilla J; Bloch Rasmussen T; Ferreira-Aguar A; Revilla-Martí P; Basurte Elorz MT; Bautista Paves A; Ramon Gimeno J; Figueroa AV; Franco-Gutierrez R; Fuentes-Cañamero ME; Martinez Moreno M; Ortiz-Genga M; Piqueras-Flores J; Analia Ramos K; Rudzitis A; Ruiz-Guerrero L; Stein R; Triguero-Bocharán M; de la Higuera L; Ochoa JP; Abu-Bonsrah D; Kwok CYT; Smith JB; Porrello ER; Akhtar MM; Jager J; Ashworth M; Syrris P; Elliott DA; Monserrat L; Elliott PM
Eur Heart J; 2021 Aug; 42(32):3063-3073. PubMed ID: 34263907
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
Jensen MK; Havndrup O; Christiansen M; Andersen PS; Axelsson A; Køber L; Bundgaard H
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1511-8. PubMed ID: 26231341
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
Keren A; Syrris P; McKenna WJ
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.
Wang B; Wang J; Wang LF; Yang F; Xu L; Li WX; He Y; Zuo L; Yang QL; Shao H; Hu D; Liu LW
Mol Med Rep; 2019 Dec; 20(6):5229-5238. PubMed ID: 31638223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
